Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 4
Submit an article Journal homepage
2,474
Views
65
CrossRef citations to date
0
Altmetric
Reviews

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus

William N WashburnMetabolic Diseases Chemistry, Research and Development, Bristol-Myers-Squibb Co., Princeton, NJ, USA+ 609 818 4971; [email protected]
&
Simon M PoucherPrincipal Scientist, Cardiovascular and Gastro-Intestinal Disorders Innovative Medicines, AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK
, BSc (Hons) PhD FBPharmacolS
Pages 463-486 | Published online: 01 Mar 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.